Investigators employ CJC-1295 with DAC to investigate its albumin-binding modification that significantly extends plasma half-life compared to native GHRH, enabling sustained pituitary stimulation. Pre-clinical observations in rodent and primate models indicate prolonged elevation of circulating GH and IGF-1 levels with preservation of pulsatile secretion characteristics.
This modified analog facilitates examination of extended receptor-mediated signaling, feedback loop interactions, and metabolic adaptations in growth factor and aging-related research paradigms.
Scientific Overview of CJC-1295 with DAC Applications
Pre-clinical models demonstrate CJC-1295 with DAC’s engagement with somatotropic mechanisms:
- Albumin bioconjugation extends half-life to several days, supporting sustained GH release from pituitary somatotrophs in pharmacokinetic studies.
- Dose-dependent elevation of circulating IGF-1 levels with maintenance of physiological pulsatile patterns in animal models.
- Promotion of protein synthesis and nitrogen retention through mTOR pathway activation in skeletal muscle systems.
- Modulation of lipolysis and lipid metabolism in adipose tissue, contributing to substrate utilization investigations.
- Support for tissue growth and repair processes in recovery and regeneration research contexts.
- Examination of long-term somatotropic axis engagement and receptor responsiveness in endocrine adaptation studies.
For additional context on long-acting GHRH analogs, IGF-1 axis modulation, and somatotropic signaling in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Commitment to Research-Grade Quality at National Science Labs
National Science Labs produces CJC-1295 with DAC under strict GMP-compliant protocols to deliver batch-to-batch consistency and reliability for pre-clinical investigations. Each lot undergoes independent third-party analysis, confirming:
- Purity ≥99.9% via HPLC
- Accurate structural identity and modification verification
- Comprehensive Certificate of Analysis (CoA) available for download per batch
For Research Use Only. This product is intended solely for in vitro and in vivo pre-clinical research by qualified investigators. Statements concerning this peptide have not been evaluated by the FDA.
Begin Your Long-Acting GHRH Research
Access current limited batches of high-purity CJC-1295 with DAC to maintain optimal stability and performance in your somatotropic axis studies.
This product is strictly for laboratory and research purposes only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any condition.









